Aardvark Therapeutics has filed a notice of an exempt offering of securities to raise $85 Million in New Equity Investment.
According to filings with the U.S. Securities and Exchange Commission, Aardvark Therapeutics is raising up to $84,999,982.00 in new funding. Sources indicate that as part of senior management Chief Executive Officer, Tien-Li Lee played a…